Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    

IMMUNOCELLULAR THERAPEUTICS LTD
Mes dernières consult.
Most popular
Report
 SummaryNewsCalendarCompanyFinancialsRevisions 
Financials ($)
More Financials
Company
ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers.The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma... 
More about the company
Latest news on IMMUNOCELLULAR THERAPEUTIC
12/13 IMMUNOCELLULAR THERAPEUTICS : Achieves Key Milestone in Stem-to-T-Cell Research ..
11/30 IMMUNOCELLULAR THERAPEUTICS : ImmuncoCellular Therapeutics to Present at the 10t..
11/22 IMMUNOCELLULAR THERAPEUTICS : ImmuncoCellular Therapeutics to Present at the 10t..
11/21 IMMUNOCELLULAR THERAPEUTICS, LTD. : Results of Operations and Financial Conditio..
11/21 IMMUNOCELLULAR THERAPEUTICS : Announces Third Quarter 2017 Financial Results
11/21 IMMUNOCELLULAR THERAPEUTICS LTD : ImmunoCellular Therapeutics, Ltd. to Host Earn..
11/17 IMMUNOCELLULAR THERAPEUTICS : to Report Third Quarter 2017 Financial Results on ..
10/30 IMMUNOCELLULAR THERAPEUTICS : Technical Snapshots for These Biotech Stocks -- Co..
10/11 IMMUNOCELLULAR THERAPEUTICS, LTD. : Regulation FD Disclosure, Financial Statemen..
10/03 IMMUNOCELLULAR THERAPEUTICS TO PRESE : 00pm ET
More news
Sector news : Biotechnology & Medical Research - NEC
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/12 Sanofi investors hungry for drug progress and deal news
12/09 Tax-loss selling to pressure 2017's losers in December
11/30 GENMAB : and J&J 'love' partnership as some ponder takeover
11/27 MERCK AND : As Brexit looms, UK pitches new industry plan, wins support from Mer..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
2016 ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q3 2016 Results - Ea..
2016 ImmunoCellular Therapeutics EPS in-line
2016 ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q2 2016 Results - Ea..
2016 ImmunoCellular Therapeutics beats by $0.01
2016 ImmunoCellular's late-stage study of lead product candidate in glioblastoma c..
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
EPS Revisions
Managers
NameTitle
Anthony J. Gringeri President, Chief Executive Officer & Director
Gary S. Titus Chairman & Secretary
David E. Fractor Chief Financial & Accounting Officer
Steven J. Swanson Senior Vice President-Research
John S. Yu Director
Sector and Competitors
1st jan.Capitalization (M$)
IMMUNOCELLULAR THERAPEUTICS LTD10
CELLTRION, INC.--.--%23 643
IQVIA HOLDINGS INC34.41%21 105
INCYTE CORPORATION-2.16%20 253
LONZA GROUP62.09%19 941
ALNYLAM PHARMACEUTICALS, INC.233.49%12 160